Peter Brauchli

Phase II Study of Capecitabine and Oxaliplatin in First- and Second-Line Treatment of Advanced or Metastatic Colorectal Cancer

Markus Borner, Daniel Dietrich, Roger Stupp et al. · Journal of Clinical Oncology · 2002 · 169 citations

Electrocortical and Autonomic Alteration by Administration of a Pleasant and an Unpleasant Odor

Peter Brauchli, Peter B. Rüegg, F. Etzweiler et al. · Chemical Senses · 1995 · 165 citations · Full text

Effects of work demands on immunoglobulin A and cortisol in air traffic controllers

Hans Zeier, Peter Brauchli, Helen I. Joller‐Jemelka · Biological Psychology · 1996 · 139 citations

Asthma, Air Traffic Controllers, Psychoneuroimmunology +6

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Dieter Koeberle, Daniel Betticher, Roger von Moos et al. · Annals of Oncology · 2015 · 139 citations · Full text

Sakk 41/06, Gastrointestinal Oncology, Medicine +9

The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MO AIC, a multicenter cluster-randomized phase III study (SAKK 95/06)

Florian Strasser, David Blum, Roger von Moos et al. · Annals of Oncology · 2015 · 126 citations · Full text

Nursing, Clinical System, Outpatient Workflow +15